|
1
|
Kwon SB, Kim MJ, Ham SY, Park GW, Choi KD,
Jung SH and Yoon DY: H9 induces apoptosis via the intrinsic pathway
in non-small-cell lung cancer A549 cells. J Microbiol Biotechnol.
25:343–352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kogita A, Togashi Y, Hayashi H, Sogabe S,
Terashima M, De Velasco MA, Sakai K, Fujita Y, Tomida S, Takeyama
Y, et al: Hypoxia induces resistance to ALK inhibitors in the H3122
non-small cell lung cancer cell line with an ALK rearrangement via
epithelial-mesenchymal transition. Int J Oncol. 45:1430–1436.
2014.PubMed/NCBI
|
|
3
|
Lønvik K, Sørbye SW, Nilsen MN and
Paulssen RH: Prognostic value of the MicroRNA regulators Dicer and
Drosha in non-small-cell lung cancer: Co-expression of Drosha and
miR-126 predicts poor survival. BMC Clin Pathol. 14:452014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nana-Sinkam SP and Geraci MW: MicroRNA in
lung cancer. J Thorac Oncol. 1:929–931. 2006. View Article : Google Scholar
|
|
5
|
Garofalo M, Quintavalle C, Di Leva G,
Zanca C, Romano G, Taccioli C, Liu CG, Croce CM and Condorelli G:
MicroRNA signatures of TRAIL resistance in human non-small cell
lung cancer. Oncogene. 27:3845–3855. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou L, Luan H, Liu Q, Jiang T, Liang H,
Dong X and Shang H: Activation of PI3K/Akt and ERK signaling
pathways antagonized sinomenine-induced lung cancer cell apoptosis.
Mol Med Rep. 5:1256–1260. 2012.PubMed/NCBI
|
|
7
|
Zito CR, Jilaveanu LB, Anagnostou V, Rimm
D, Bepler G, Maira SM, Hackl W, Camp R, Kluger HM and Chao HH:
Multi-level targeting of the phosphatidylinositol-3-kinase pathway
in non-small cell lung cancer cells. PLoS One. 7:e313312012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen QY, Jiao DM, Wang LF, Wang L, Hu HZ,
Song J, Yan J, Wu LJ and Shi JG: Curcumin inhibits
proliferation-migration of NSCLC by steering crosstalk between a
Wnt signaling pathway and an adherens junction via EGR-1. Mol
Biosyst. 11:859–868. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu W, Jiang JP, Hu J, Wang J and Zheng MZ:
Curcumin protects against lipopolysaccharide-induced
vasoconstriction dysfunction via inhibition of thrombospondin-1 and
transforming growth factor-β1. Exp Ther Med. 9:377–383.
2015.PubMed/NCBI
|
|
10
|
Tizabi Y, Hurley LL, Qualls Z and
Akinfiresoye L: Relevance of the anti-inflammatory properties of
curcumin in neurodegenerative diseases and depression. Molecules.
19:20864–20879. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Borra SK, Mahendra J, Gurumurthy P,
Jayamathi, Iqbal SS and Mahendra L: Effect of curcumin against
oxidation of biomolecules by hydroxyl radicals. J Clin Diagn Res.
8:CC01–CC05. 2014.PubMed/NCBI
|
|
12
|
Nahar PP, Slitt AL and Seeram NP:
Anti-inflammatory effects of novel standardized solid lipid
curcumin formulations. J Med Food. 18:786–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ali MS, Pandit V, Jain M and Dhar KL:
Mucoadhesive micropar-ticulate drug delivery system of curcumin
against Helicobacter pylori infection: Design, development and
optimization. J Adv Pharm Technol Res. 5:48–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang T, Cui GB, Zhang J, Zhang F, Zhou
YA, Jiang T and Li XF: Inhibition of PI3 kinases enhances the
sensitivity of non-small cell lung cancer cells to ionizing
radiation. Oncol Rep. 24:1683–1689. 2010.PubMed/NCBI
|
|
15
|
Li H, Xie L and Lai RS: Association of
EGFR mutations with low BRCA1 gene expression in non-small cell
lung cancer. Mol Clin Oncol. 1:195–199. 2013.PubMed/NCBI
|
|
16
|
Liu X, Sun K, Song A, Zhang X, Zhang X and
He X: Curcumin inhibits proliferation of gastric cancer cells by
impairing ATP-sensitive potassium channel opening. World J Surg
Oncol. 12:3892014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma J, Fang B, Zeng F, Pang H, Zhang J, Shi
Y, Wu X, Cheng L, Ma C, Xia J, et al: Curcumin inhibits cell growth
and invasion through up-regulation of miR-7 in pancreatic cancer
cells. Toxicol Lett. 231:82–91. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li M, Zhang Q, Wu L, Jia C, Shi F, Li S,
Peng A, Zhang G, Song X and Wang C: Serum miR-499 as a novel
diagnostic and prognostic biomarker in non-small cell lung cancer.
Oncol Rep. 31:1961–1967. 2014.PubMed/NCBI
|
|
19
|
Pacurari M, Addison JB, Bondalapati N, Wan
YW, Luo D, Qian Y, Castranova V, Ivanov AV and Guo NL: The
microRNA-200 family targets multiple non-small cell lung cancer
prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol.
43:548–560. 2013.PubMed/NCBI
|
|
20
|
Bandi N, Zbinden S, Gugger M, Arnold M,
Kocher V, Hasan L, Kappeler A, Brunner T and Vassella E: miR-15a
and miR-16 are implicated in cell cycle regulation in a
Rb-dependent manner and are frequently deleted or down-regulated in
non-small cell lung cancer. Cancer Res. 69:5553–5559. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye M and Zhang J and Zhang J, Miao Q, Yao
L and Zhang J: Curcumin promotes apoptosis by activating the
p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
Cancer Lett. 357:196–205. 2015. View Article : Google Scholar
|
|
22
|
Yue W, Wang X and Wang Y: The relationship
between the PI3K/Akt/mTOR signal transduction pathway and non-small
cell lung cancer. Zhongguo Fei Ai Za Zhi. 12:312–315. 2009.In
Chinese. PubMed/NCBI
|
|
23
|
Baykara O, Tansarikaya M, Demirkaya A,
Kaynak K, Tanju S, Toker A and Buyru N: Association of epidermal
growth factor receptor and K-Ras mutations with smoking history in
non-small cell lung cancer patients. Exp Ther Med. 5:495–498.
2013.PubMed/NCBI
|
|
24
|
Xu X, Qin J and Liu W: Curcumin inhibits
the invasion of thyroid cancer cells via down-regulation of
PI3K/Akt signaling pathway. Gene. 546:226–232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu Y, Zhang J, Han J, Pan X, Cao Y, Guo H,
Pan Y, An Y and Li X: Curcumin inhibits tumor proliferation induced
by neutrophil elastase through the upregulation of α1-antitrypsin
in lung cancer. Mol Oncol. 6:405–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schee K, Lorenz S, Worren MM, Günther CC,
Holden M, Hovig E, Fodstad O, Meza-Zepeda LA and Flatmark K: Deep
Sequencing the MicroRNA Transcriptome in Colorectal Cancer. PLoS
One. 8:e661652013. View Article : Google Scholar : PubMed/NCBI
|
